ZA200301403B - Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain. - Google Patents

Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain. Download PDF

Info

Publication number: ZA200301403B
Authority: ZA; South Africa
Prior art keywords: formula; enantiomer; predominates; enantiomers; substantially free
Prior art date: 2000-07-21

Application number

ZA200301403A

Other languages

English (en)

Inventor

Ellen E Codd

Katherine E Rogers

Boyu Zhao

Richard P Shank

Carlos R Plata-Salaman

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-21

Filing date

2003-02-20

Publication date

2004-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22820176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200301403(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-02-20 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2004-06-15 Publication of ZA200301403B publication Critical patent/ZA200301403B/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ZA200301403A 2000-07-21 2003-02-20 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain. ZA200301403B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US21965700P	2000-07-21	2000-07-21

Publications (1)

Publication Number	Publication Date
ZA200301403B true ZA200301403B (en)	2004-06-15

Family

ID=22820176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200301403A ZA200301403B (en)	2000-07-21	2003-02-20	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain.

Country Status (28)

Country	Link
US (4)	US20020107283A1 (de)
EP (1)	EP1305082B1 (de)
JP (1)	JP5271473B2 (de)
KR (1)	KR100792814B1 (de)
CN (1)	CN1250213C (de)
AT (1)	ATE267629T1 (de)
AU (2)	AU2001273493B2 (de)
BG (1)	BG107529A (de)
BR (1)	BR0112713A (de)
CA (1)	CA2416819C (de)
CZ (1)	CZ2003445A3 (de)
DE (1)	DE60103546T2 (de)
DK (1)	DK1305082T3 (de)
EA (1)	EA005648B1 (de)
ES (1)	ES2221651T3 (de)
HU (1)	HUP0302940A3 (de)
IL (2)	IL154052A0 (de)
MX (1)	MXPA03000619A (de)
MY (1)	MY127317A (de)
NO (1)	NO330055B1 (de)
NZ (1)	NZ523851A (de)
PL (1)	PL365701A1 (de)
PT (1)	PT1305082E (de)
SK (1)	SK1962003A3 (de)
TR (1)	TR200401511T4 (de)
UA (1)	UA74195C2 (de)
WO (1)	WO2002007822A2 (de)
ZA (1)	ZA200301403B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60238765D1 (de) *	2001-02-27	2011-02-10	Ortho Mcneil Pharm Inc	Carbamatverbindungen zur behandlung von schmerz
PT1408954E (pt)	2001-07-16	2009-07-28	Ortho Mcneil Janssen Pharm	Compostos carbamatos para utilização na prevenção ou tratamento da dor neuropática
CN101669933A (zh) *	2001-07-16	2010-03-17	奥索-麦克尼尔药品公司	用于预防或治疗神经性疼痛和丛集性头痛及偏头痛性疼痛的氨基甲酸酯化合物
US20040087642A1 (en) *	2002-10-24	2004-05-06	Zeldis Jerome B.	Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
US7323443B2 (en) *	2002-12-12	2008-01-29	Agennix Inc.	Lactoferrin in the reduction of pain
US7183381B2 (en) *	2004-10-26	2007-02-27	Agennix, Inc.	Composition of lactoferrin related peptides and uses thereof
JP2008528489A (ja) *	2005-01-20	2008-07-31	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Ｑｔ間隔調節方法
EP1998802A2 (de)	2006-03-30	2008-12-10	GlaxoSmithKline Biologicals S.A.	Immunogene zusammensetzung
KR20090082209A (ko) *	2006-10-10	2009-07-29	얀센 파마슈티카 엔.브이.	신규 (ｓ)-(＋)-2-(2-클로로페닐)-2-하이드록시-에틸 카바메이트 결정
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US20150057351A1 (en) *	2013-08-22	2015-02-26	Sucampo Ag	Method for treating neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3278380A (en) *	1962-02-06	1966-10-11	Armour Pharma	Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) *	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
HU191549B (en) *	1984-04-11	1987-03-30	Richter Gedeon Vegyeszet	Process for producing 1-/6-/2 comma above-substituted-5 comma above, 6 comma above, 7 comma above, 8 comma above-tetrahydro-4 comma above-oxo-quinazolino//-3,4-dihydro-6,7-disubstituted-isoquinoline derivatives
US4868190A (en) *	1988-12-27	1989-09-19	Hoechst-Roussel Pharmaceuticals, Inc.	N-pyridinyl-9H-carbazol-9-amines
GB9518027D0 (en) *	1995-09-05	1995-11-08	Wellcome Found	Pharmacologically active compound
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
IL133242A0 (en) *	1997-06-05	2001-03-19	Sanofi Synthelabo	5-Naphthalene-1-yl-1,3-dioxane derivatives their preparation and their therapeutic application
CN1262272C (zh) *	2001-02-27	2006-07-05	奥索-麦克尼尔药品公司	用于预防或治疗运动障碍的氨基甲酸酯化合物
CZ302412B6 (cs) *	2001-02-27	2011-05-04	Ortho-Mcneil Pharmaceutical, Inc.	Lécivo pro prevenci nebo lécbu psychotických chorob
CA2439475C (en) *	2001-02-27	2010-05-18	Carlos R. Plata-Salaman	Carbamate compounds for use in preventing or treating bipolar disorder

2001
- 2001-07-16 CZ CZ2003445A patent/CZ2003445A3/cs unknown
- 2001-07-16 IL IL15405201A patent/IL154052A0/xx unknown
- 2001-07-16 AT AT01952773T patent/ATE267629T1/de not_active IP Right Cessation
- 2001-07-16 HU HU0302940A patent/HUP0302940A3/hu unknown
- 2001-07-16 ES ES01952773T patent/ES2221651T3/es not_active Expired - Lifetime
- 2001-07-16 BR BR0112713-6A patent/BR0112713A/pt not_active Application Discontinuation
- 2001-07-16 CN CNB01815798XA patent/CN1250213C/zh not_active Expired - Fee Related
- 2001-07-16 US US09/906,251 patent/US20020107283A1/en not_active Abandoned
- 2001-07-16 JP JP2002513552A patent/JP5271473B2/ja not_active Expired - Lifetime
- 2001-07-16 EP EP01952773A patent/EP1305082B1/de not_active Expired - Lifetime
- 2001-07-16 AU AU2001273493A patent/AU2001273493B2/en not_active Ceased
- 2001-07-16 DE DE60103546T patent/DE60103546T2/de not_active Expired - Lifetime
- 2001-07-16 WO PCT/US2001/022322 patent/WO2002007822A2/en not_active Ceased
- 2001-07-16 CA CA2416819A patent/CA2416819C/en not_active Expired - Fee Related
- 2001-07-16 KR KR1020037000914A patent/KR100792814B1/ko not_active Expired - Lifetime
- 2001-07-16 SK SK196-2003A patent/SK1962003A3/sk unknown
- 2001-07-16 EA EA200300042A patent/EA005648B1/ru not_active IP Right Cessation
- 2001-07-16 DK DK01952773T patent/DK1305082T3/da active
- 2001-07-16 AU AU7349301A patent/AU7349301A/xx active Pending
- 2001-07-16 PT PT01952773T patent/PT1305082E/pt unknown
- 2001-07-16 MX MXPA03000619A patent/MXPA03000619A/es active IP Right Grant
- 2001-07-16 TR TR2004/01511T patent/TR200401511T4/xx unknown
- 2001-07-16 PL PL01365701A patent/PL365701A1/xx not_active Application Discontinuation
- 2001-07-16 NZ NZ523851A patent/NZ523851A/en unknown
- 2001-07-16 UA UA2003010559A patent/UA74195C2/uk unknown
- 2001-07-20 MY MYPI20013443 patent/MY127317A/en unknown
2003
- 2003-01-20 IL IL154052A patent/IL154052A/en unknown
- 2003-01-20 NO NO20030299A patent/NO330055B1/no not_active IP Right Cessation
- 2003-02-05 BG BG107529A patent/BG107529A/bg unknown
- 2003-02-20 ZA ZA200301403A patent/ZA200301403B/en unknown
2004
- 2004-06-15 US US10/868,633 patent/US20040266866A1/en not_active Abandoned
2005
- 2005-02-18 US US11/194,876 patent/US20060183795A1/en not_active Abandoned
2009
- 2009-07-20 US US12/505,765 patent/US20090281179A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2416819A1 (en)	2002-01-31
EA200300042A1 (ru)	2003-06-26
CZ2003445A3 (cs)	2004-08-18
HUP0302940A2 (hu)	2003-12-29
ES2221651T3 (es)	2005-01-01
HUP0302940A3 (en)	2012-02-28
MY127317A (en)	2006-11-30
AU2001273493B2 (en)	2005-08-11
AU7349301A (en)	2002-02-05
EP1305082A2 (de)	2003-05-02
BR0112713A (pt)	2003-07-22
MXPA03000619A (es)	2004-07-30
DE60103546T2 (de)	2005-06-09
DE60103546D1 (de)	2004-07-01
US20020107283A1 (en)	2002-08-08
IL154052A0 (en)	2003-07-31
US20090281179A1 (en)	2009-11-12
JP5271473B2 (ja)	2013-08-21
UA74195C2 (uk)	2005-11-15
CN1250213C (zh)	2006-04-12
EP1305082B1 (de)	2004-05-26
BG107529A (bg)	2003-09-30
DK1305082T3 (da)	2004-09-13
ATE267629T1 (de)	2004-06-15
JP2004504362A (ja)	2004-02-12
CA2416819C (en)	2011-03-22
KR100792814B1 (ko)	2008-01-14
NO330055B1 (no)	2011-02-14
CN1458853A (zh)	2003-11-26
NO20030299D0 (no)	2003-01-20
WO2002007822A2 (en)	2002-01-31
TR200401511T4 (tr)	2004-08-23
KR20030022300A (ko)	2003-03-15
PL365701A1 (en)	2005-01-10
US20060183795A1 (en)	2006-08-17
NO20030299L (no)	2003-03-12
WO2002007822A3 (en)	2002-05-30
US20040266866A1 (en)	2004-12-30
PT1305082E (pt)	2004-09-30
EA005648B1 (ru)	2005-04-28
IL154052A (en)	2008-07-08
SK1962003A3 (en)	2004-08-03
NZ523851A (en)	2004-09-24

Publication	Publication Date	Title
US20090281179A1 (en)	2009-11-12	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache associated pain
AU2001273493A1 (en)	2002-05-02	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
EP1408954B1 (de)	2009-07-01	Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
AU2002354909B2 (en)	2006-10-05	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
AU2002322442B2 (en)	2007-06-07	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
AU2002354909A1 (en)	2003-05-22	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
AU2002322442A1 (en)	2003-05-22	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
HK1063435B (en)	2010-01-22	Carbamate compounds for use in preventing or treating neuropathic pain
ZA200401156B (en)	2005-06-22	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain.
HK1063288B (en)	2007-05-25	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
ZA200401155B (en)	2005-05-12	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain.